Dan Monahan will serve in the role as the drug goes through Phase III trials.
Amylyx Names New Chief Commercial Officer Ahead of GLP-1 Commercialization
You May Also Like
Global Launch Strategies in the Current Political Climate
February 19, 2025
FDA Approves Samsung Bioepis Biosimilars Ospomyv and Xbryk
February 19, 2025
Navigating Distrust: Pharma in the Age of Social Media
February 18, 2025
+ There are no comments
Add yours